TABLE 1.
Gender | 93% Male, 3% Female, 3% Male-to-female |
Age (years) | 47 (45–50) |
CD4+ T cell count (cells/mm3) | 62 (8–268) |
Plasma HIV RNA (log10 copies/mL) | 4.65 (4.12–5.36) |
Number of prior ARV | 12 (9–16) |
Number of prior ARV drug classes | 4 (3–4) |
Duration of follow-up (months) | 15.8 (12.4–17.5) |
Data are medians with interquartile ranges (IQR). ARV=antiretroviral drugs.